chr20-63687765-G-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PP5_Very_Strong
The NM_001283009.2(RTEL1):c.1476G>T(p.Met492Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 1,572,500 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
RTEL1
NM_001283009.2 missense
NM_001283009.2 missense
Scores
5
10
4
Clinical Significance
Conservation
PhyloP100: 9.46
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PP5
Variant 20-63687765-G-T is Pathogenic according to our data. Variant chr20-63687765-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 42019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTEL1 | NM_001283009.2 | c.1476G>T | p.Met492Ile | missense_variant | 17/35 | ENST00000360203.11 | NP_001269938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.1476G>T | p.Met492Ile | missense_variant | 17/35 | 5 | NM_001283009.2 | ENSP00000353332.5 | ||
RTEL1 | ENST00000508582.7 | c.1548G>T | p.Met516Ile | missense_variant | 17/35 | 2 | ENSP00000424307.2 | |||
RTEL1 | ENST00000370018.7 | c.1476G>T | p.Met492Ile | missense_variant | 17/35 | 1 | ENSP00000359035.3 | |||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.1560G>T | non_coding_transcript_exon_variant | 15/35 | 5 | ENSP00000457428.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152264Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152264
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000488 AC: 9AN: 184516Hom.: 0 AF XY: 0.0000605 AC XY: 6AN XY: 99110
GnomAD3 exomes
AF:
AC:
9
AN:
184516
Hom.:
AF XY:
AC XY:
6
AN XY:
99110
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000211 AC: 30AN: 1420236Hom.: 0 Cov.: 32 AF XY: 0.0000213 AC XY: 15AN XY: 703182
GnomAD4 exome
AF:
AC:
30
AN:
1420236
Hom.:
Cov.:
32
AF XY:
AC XY:
15
AN XY:
703182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74388
GnomAD4 genome
AF:
AC:
1
AN:
152264
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Dyskeratosis congenita, autosomal recessive 5 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 03, 2013 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 21, 2024 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2023 | Published functional studies demonstrate telomere shortening, fragility and fusion, and growth defects (PMID: 23959892); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as M492I; This variant is associated with the following publications: (PMID: 23453664, 27418648, 27415407, 19461895, 25047097, 23959892, 32561545, 32542379, 25940403) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 10, 2022 | - - |
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 16, 2023 | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 492 of the RTEL1 protein (p.Met492Ile). This variant is present in population databases (rs370343781, gnomAD 0.09%). This missense change has been observed in individual(s) with Hoyeraal–Hreidarsson syndrome and myelodysplastic syndrome (PMID: 19461895, 23453664, 23959892, 27418648). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.1548G>T (p.Met516Ile). ClinVar contains an entry for this variant (Variation ID: 42019). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects RTEL1 function (PMID: 19461895, 23959892). This variant disrupts the p.Met492 amino acid residue in RTEL1. Other variant(s) that disrupt this residue have been observed in individuals with RTEL1-related conditions (PMID: 26808564), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Dyskeratosis congenita Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 16, 2016 | Variant summary: The RTEL1 c.1548G>T (p.Met516Ile) variant involves the alteration of a conserved nucleotide. 2/3 in silico tools used predict a damaging outcome. This variant was found in 2/35814 control chromosomes at a frequency of 0.0000558, which does not exceed the estimated maximal expected allele frequency of a pathogenic RTEL1 variant (0.001118). This variant has been detected in four affected siblings from a family who were compound heterozygous for this variant and R998X. The parents were carriers of either of the mutations and an unaffected grandfather carried this variant in heterozygous state. This family data is consistent with disease causing outcome of the variant. Functional studies using patient cells showed telomere shortening, increased senescence, and an increased frequency of telomere defects, such as fragile telomeres and signal-free ends, but no increase in pathogenic T-circle formation on 2D gel electrophoresis (Deng_2013). The same authors also showed minor changes in telomere length caused by the variant in vitro. Jalas (2013) reports the carrier frequency of this variant in AJ as 0.19%. Two reputable databases have classified this variant as pathogenic. Taken together, this variant is currently classified as a Probable Disease Variant (or Likely Pathogenic). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;.
REVEL
Pathogenic
Sift
Benign
T;D;D;.
Sift4G
Benign
T;T;T;T
Polyphen
B;P;B;.
Vest4
MutPred
Gain of sheet (P = 0.1208);.;Gain of sheet (P = 0.1208);.;
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at